Leila Alland - 12 May 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: Chief Medical Officer
Signature: /s/ Winston Kung, by power of attorney
Issuer symbol: PMVP
Transactions as of: 12 May 2021
Net transactions value: -$118,787
Form type: 4
Filing time: 08 Jun 2021, 19:22:02 UTC
Previous filing: 10 May 2021
Next filing: 27 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Options Exercise	$15,600	+4,000		$3.90	4,000	07 Jun 2021	Direct
transaction	PMVP	Common Stock	Sale	$87,903	-2,633	-66%	$33.39	1,367	07 Jun 2021	Direct	F1, F2
transaction	PMVP	Common Stock	Sale	$46,484	-1,367	-100%	$34.00	0	07 Jun 2021	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Award	$0	+36,279		$0.000000	36,279	12 May 2021	Common Stock	36,279	$28.33	Direct	F4
transaction	PMVP	Employee Stock Option (right to buy)	Options Exercise	$0	-4,000	-1.1%	$0.000000	365,850	07 Jun 2021	Common Stock	4,000	$3.90	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.705 to $33.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.705 to $34.255, inclusive.
F4	Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
F5	One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.